Table 1.
≥ 90% ART Adherence (N = 80) |
< 90 % ART Adherence (N = 46) |
No Stimulant Use (N = 83) |
Monthly Stimulant Use (N = 44) |
Weekly Stimulant Use (n =27) |
|
---|---|---|---|---|---|
M (SD) | M (SD) | M (SD) | M (SD) | M (SD) | |
HIV Viral Load (log10) | 2.76 (1.23)a | 3.49 (1.27)a | 2.92 (1.25)c | 3.25 (1.34) | 3.65 (1.31)c |
CD4+ Count | 498.78 (308.71) | 438.57 (316.03) | 494.81 (297.38) | 436.07 (335.64) | 435.31 (365.12) |
Neopterin (log10) | 1.00 (.24)a | 1.12 (.26)a | 1.01 (.25)b,c | 1.12 (.23)b | 1.18 (.22)c |
Tryptophan | 49.07 (11.20) | 45.99 (13.23) | 49.12 (12.70)c | 45.31 (10.38) | 40.66 (8.25)c |
Kynurenine (square root) | 1.47 (.30) | 1.53 (.39) | 1.53 (.36) | 1.43 (.28) | 1.41 (.25) |
Kynurenine/ Tryptophan | 47.64 (20.42) | 53.06 (28.16) | 50.65 (25.08) | 48.85 (21.75) | 52.59 (22.12) |
significant independent samples t-test (p < .05)